SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000927016-99-000575
Filing Date
1999-02-12
Accepted
1999-02-12 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A - AMENDMENT NO. 2 SC 13G/A 9896
  Complete submission text file 0000927016-99-000575.txt   11888
Mailing Address 360 LEXINGTON AVENUE C/O IMMUNOTHERAPY INC NEW YORK NY 10017
Business Address 360 LEXINGTON AVENUE C/O IMMUNOTHERAPY INC NEW YORK NY 10017 2125994455
GORDON C LEONARD (Filed by) CIK: 0000931575 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 27 WORMWOOD STREET BOSTON MA 02210
Business Address 27 WORMWOOD STREET BOSTON MA 02210 6177370930
NITINOL MEDICAL TECHNOLOGIES INC (Subject) CIK: 0001017259 (see all company filings)

IRS No.: 954090463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48983 | Film No.: 99534968
SIC: 3841 Surgical & Medical Instruments & Apparatus